Table 1.
The clinical characteristic information of patients from the training cohort with ccRCC in The Cancer Genome Atlas database related genes.
| Training | TCGA-KIRC | High risk score | Low risk score |
|---|---|---|---|
| Cohort | (n = 331) | (n = 166) | (n = 165) |
| Number of patients | 531 | 266 | 265 |
| T_Stage | |||
| T1 | 160 (48.34%) | 64 (38.55%) | 96 (58.18%) |
| T2 | 42 (12.69%) | 22 (13.25%) | 20 (12.12%) |
| T3 | 120 (36.25%) | 71 (42.77%) | 49 (29.70%) |
| T4 | 9 (2.72%) | 9 (5.42%) | 0 (0.00%) |
| N_Stage | |||
| N0 | 149 (45.02%) | 73 (43.98%) | 76 (46.06%) |
| N1 | 13 (3.93%) | 7 (4.22%) | 6 (3.64%) |
| NX | 169 (51.06%) | 86 (51.81%) | 83 (50.30%) |
| M_Stage | |||
| NA | 1 (0.30%) | 1 (0.60%) | 0 (0.00%) |
| M0 | 262 (79.15%) | 123 (74.10%) | 139 (84.24%) |
| M1 | 51 (15.41%) | 34 (20.48%) | 17 (10.30%) |
| MX | 17 (5.14%) | 8 (4.82%) | 9 (5.45%) |
| Stage | |||
| NR | 3 (0.91%) | 2 (1.20%) | 1 (0.61%) |
| Stage I | 156 (47.13%) | 62 (37.35%) | 94 (56.97%) |
| Stage II | 34 (10.27%) | 16 (9.64%) | 18 (10.91%) |
| Stage III | 85 (25.68%) | 50 (30.12%) | 35 (21.21%) |
| Stage IV | 53 (16.01%) | 36 (21.69%) | 17 (10.30%) |
| OS | |||
| Mean | 1340.29 | 1191.33 | 1490.15 |
| Median | 1218.00 | 1138.50 | 1314.00 |
| Age | |||
| ≤ 60 | 160 (48.34%) | 81 (48.80%) | 79 (47.88%) |
| > 60 | 171 (51.66%) | 85 (51.20%) | 86 (52.12%) |
| Gender | |||
| Female | 114 (34.44%) | 49 (29.52%) | 65 (39.39%) |
| Male | 217 (65.56%) | 117 (70.48%) | 100 (60.61%) |